BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) Stock Income Statement
NASDAQ:BBOT - KYG4444H1011 - Common Stock
9.45 USD
+0.15 (+1.61%)
9.44 USD
-0.01 (-0.11%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 3.91M | 584.40K | 41.70K | 3.50K | 43.40K | |||
| Selling, General, and Administrative Expenses | 3.91M | 584.40K | N/A | N/A | N/A | |||
| Operating Income | -3.91M | -584.40K | -41.70K | -3.50K | -43.40K | |||
| Interest Income/Expense | 8.87M | 8.46M | N/A | N/A | N/A | |||
| Other Income/Expense | -248.70K | -271.60K | N/A | N/A | N/A | |||
| Income Before Taxes | 4.72M | 7.60M | -41.70K | -3.50K | -43.40K | |||
| Net Income | 4.72M | 7.60M | -41.70K | -3.50K | -43.40K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.20 | 0.36 | 0.00 | 0.00 | 0.00 | |||
| Statistics | ||||||||
All data in USD